Reduction in focal cerebral ischemia by agents acting at imidazole receptors.
about
Biological significance of agmatine, an endogenous ligand at imidazoline binding sitesDiabetes mellitus: channeling care through cellular discoveryWnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways.Novel avenues of drug discovery and biomarkers for diabetes mellitus.The involvement of pertussis toxin-sensitive G proteins in the post receptor mechanism of central I1-imidazoline receptorsAttenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor.RS-45041-190: a selective, high-affinity ligand for I2 imidazoline receptors.Reductions in focal ischemic infarctions elicited from cerebellar fastigial nucleus do not result from elevations in cerebral blood flow.High-Throughput Phenotypic Screening of Human Astrocytes to Identify Compounds That Protect Against Oxidative Stress.Neuroprotection by alpha 2-adrenergic agonists in cerebral ischemia.The vitamin nicotinamide: translating nutrition into clinical care.Role of imidazoline receptors in halothane-epinephrine arrhythmias.Protein kinases modulate the sensitivity of hippocampal neurons to nitric oxide toxicity and anoxia.Stimulation of the fastigial nucleus enhances EEG recovery and reduces tissue damage after focal cerebral ischemia.Imidazoline receptor agonist drugs: a new approach to the treatment of systemic hypertension.Current status of putative imidazoline (I1) receptors and renal mechanisms in relation to their antihypertensive therapeutic potential.Induction of reactive astrocytosis and prevention of motoneuron cell death by the I(2)-imidazoline receptor ligand LSL 60101.The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain.Protection in glutamate-induced neurotoxicity by imidazoline receptor agonist moxonidine.Attenuation of tolerance to opioid-induced antinociception by idazoxan and other I2-ligands.Clonidine abolishes the adverse effects on apoptosis and behaviour after neonatal ketamine exposure in mice.Attenuation of ischemia-induced rat brain injury by 2-(-2-benzofuranyl)-2-imidazoline, a high selectivity ligand for imidazoline I(2) receptors.Inhibition of nitric oxide synthesis increases focal ischemic infarction in rat.Pharmacologic and molecular discrimination of I2-imidazoline receptor subtypes.Neuronal survival: cellular and molecular pathways of protection.Central neurogenic neuroprotection: central neural systems that protect the brain from hypoxia and ischemia.
P2860
Q24673628-68FDE639-2F23-4D67-8F0F-008BB9ABA9CFQ33749358-B950534C-FA35-44AA-9D6C-8991844EFF39Q34185844-75FC4CA3-A3C3-45DA-8E44-B622C5D19421Q34552287-E7B93F09-CB5C-4D24-A7B0-F5E4B0C68BAFQ35025982-6400F070-BB38-4D65-A8EE-97B00EE666A7Q35027984-220EC4DA-5120-4CEB-A42C-78A58925372BQ35566498-CAE98680-1417-4380-92D3-F62647DC713BQ35872992-2691E64C-F027-46B0-B211-5F909361F087Q36773764-1E5C4353-2481-4085-82A4-3F7E43A1B322Q36808557-876439BE-59D2-41AA-BFDB-7730E4C65E2AQ37120231-64055C1F-A56B-4B95-9D39-E67CAA66F5A9Q37374047-3D9A4E39-BD5C-4358-8C46-0B80EB6889DFQ40484007-A62379BC-C3F7-41C8-B10B-74766B9EC67DQ41069388-FB84E233-0C18-4BAD-807C-359F273A4D6DQ41096513-F9550122-DF9D-4305-9625-6FE2AF4E2573Q41148000-7167DF74-4690-4F58-B71D-A28EBB2F9775Q41205146-D2887226-AEF0-44B0-A40C-B3E81A7C108AQ41906787-0AED1406-62EE-47C1-A7C4-2373F00EF247Q42118373-C896EFDA-0C89-4993-8747-D4449767F257Q43239576-F82B5510-FA64-4A8B-8282-0F1E5D49AA09Q44352404-6BE10C64-AFB0-49AD-A8FC-4104BE7B2EFFQ44856346-91ACACC6-1AB2-4C0E-9CE2-74912545923BQ45976380-44461C3A-885B-4900-9FEB-0F893DB1B0C5Q46145584-9A4CEC44-093C-40D9-BF3B-63962D66645EQ48155212-31C59B21-46E0-4BD2-9D10-2B11C7037973Q48455032-C8CC296F-C484-452A-A231-ABCE592D57C0Q48455084-B5C59941-E2A3-4DB2-AC98-D644FE1B7A7C
P2860
Reduction in focal cerebral ischemia by agents acting at imidazole receptors.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Reduction in focal cerebral ischemia by agents acting at imidazole receptors.
@en
Reduction in focal cerebral ischemia by agents acting at imidazole receptors.
@nl
type
label
Reduction in focal cerebral ischemia by agents acting at imidazole receptors.
@en
Reduction in focal cerebral ischemia by agents acting at imidazole receptors.
@nl
prefLabel
Reduction in focal cerebral ischemia by agents acting at imidazole receptors.
@en
Reduction in focal cerebral ischemia by agents acting at imidazole receptors.
@nl
P2093
P2860
P356
P1476
Reduction in focal cerebral ischemia by agents acting at imidazole receptors.
@en
P2093
P2860
P356
10.1038/JCBFM.1992.7
P577
1992-01-01T00:00:00Z